Click here for slides on this topic


Cerebrovascular disease

Group of brain dysfunctions related to disease of the blood vessels supplying the brain. Hypertension is the most important risk factor.
The following content matched the glossary term: Cerebrovascular disease

Low HDL cholesterol ass’d w/ the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages

Top

Hayashi T, Kawashima S, Itoh H, et al, for the Japan CDM Group. Low HDL cholesterol is associated with the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages. Diabetes Care. 2009;32(7):1221-1223. To clarify the relationship between lipid levels and ischemic heart disease (IHD) and cerebrovascular disease (CVD) in diabetic individuals.

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

Top

Ogawa H, Nakayama M, Morimoto T, Uemura S, et al, for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008;300(18):2134-2141. Previous trials have investigated the effects of low-dose aspirin on primary prevention of cardiovascular events, but not in patients with type 2 diabetes.

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Top

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-53. Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents.

Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus

Top

Irons BK, Greene RS, Mazzolini TA, Edwards KL, Sleeper RB. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus. Pharmacotherapy. 2006;26:168-181. Clinical data suggest that thiazolidinediones--specifically, rosiglitazone and pioglitazone--may improve cardiovascular risk factors through multiple mechanisms. Low insulin sensitivity has been described as an independent risk factor for coronary artery disease and cerebrovascular disease. 

Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis

Top

Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ. 2004;171:1189-1192. Given that most deaths among patients with diabetes mellitus are due to cardiovascular disease, we sought to determine the extent to which medications proven to reduce cardiovascular mortality are prescribed for patients with type 2 diabetes who have symptomatic atherosclerosis

Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients with Impaired Glucose Tolerance: The STOP-NIDDM Trial

Top

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients with Impaired Glucose Tolerance: The STOP-NIDDM Trial. JAMA. 2003;290:486-494. OBJECTIVE: To evaluate the effect of decreasing postprandial hyperglycemia with acarbose, an alpha-glucosidase inhibitor, on the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance (IGT).

The Direct Medical Cost of Type 2 Diabetes

Top

Brandle M, Zhou H, Smith BRK, et al. The Direct Medical Cost of Type 2 Diabetes. Diabetes Care. 2003;26:2300-2304. To describe the direct medical costs associated with type 2 diabetes, as well as its treatments, complications, and comorbidities.

Usefulness of Home Blood Pressure Measurement in the Morning in Type 2 Diabetic Patients

Top

Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O. Usefulness of Home Blood Pressure Measurement in the Morning in Type 2 Diabetic Patients. Diabetes Care. 2002;25:2218-2223. Recently, repeated home blood pressure (HBP) measurements in the morning for a long period have been shown to have a stronger predictive power for mortality in patients with hypertension than occasional casual/clinic blood pressure (CBP) measurements. We studied whether HBP in the morning in type 2 diabetic patients is useful for prediction of diabetic complications.



Slide Library Results

Search Results for: Cerebrovascular disease Slides Found: 13
Diabetes Is Undertreated Even When Atherosclerosis Present
Effect of Early Hypertension Control on CV Events in Diabetes: Design
HPS2-THRIVE: Baseline Characteristics
AIM-HIGH: Baseline Characteristics
ESH/ESC Hypertension Guidelines: Hypertension Treatment for Patients With Cerebrovascular Disease
IDF 2012 Type 2 Diabetes Guidelines Blood Pressure Treatment | NDEI
Edinburgh Type 2 Diabetes Hypoglycemia Macrovascular Slides PPT | NDEI
Edinburgh Type 2 Diabetes Inflammation Doesn't Influence Hypoglycemia Slides PPT | NDEI
ACCELERATE CETP Inhibitor Trial Ended Early Due to Futility
IRIS Design Pioglitazone Effect on Cerebrovascular Disease Stroke PPT | NDEI
IRIS Pioglitazone Lowers Risk for Stroke and TIA Vs Placebo PPT | NDEI
IRIS Pioglitazone Lowers Rate of Progression to Diabetes Vs Placebo | NDEI
IRIS Safety of Pioglitazone Vs Placebo After Stroke or TIA PPT | NDEI